Last reviewed · How we verify

NCT03354364

Efficacy of Pea Hull Fiber in Chronic Disease

Completed NA Last updated 25 September 2019
What this trial tests

NA trial testing Pea hull fiber in Kidney Disease, Chronic in 23 participants. Completed in 19 August 2019.

Timeline
11 December 2017
Primary endpoint
30 June 2019
19 August 2019

Quick facts

Lead sponsorUniversity of Florida
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeother
Enrollment23
Start date11 December 2017
Primary completion30 June 2019
Estimated completion19 August 2019
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Florida

Who can join

Adults 18 to 100, any sex, with Kidney Disease, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the effects of daily consumption of snacks with and without pea hull fiber on gastrointestinal function, gastrointestinal symptoms, food intake, appetite, changes in fecal and microbial composition and activity. Fifty maintenance hemodialysis hemodialysis and CKD patients in stage 4 or 5 will be recruited to participate in a randomized, blinded, 13-week cross-over study evaluating snack foods containing 15 g/d of pea hull fiber.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pea hull fiber supplementation does not modulate uremic metabolites in adults receiving hemodialysis: a randomized, double-blind, controlled trial.
    Fatani AMN, Suh JH, Auger J, Alabasi KM, et al · · 2023 · cited 6× · PMID 37457968 · DOI 10.3389/fnut.2023.1179295

Verify or expand the search:

Other recruiting trials for Kidney Disease, Chronic

Currently open trials in the same condition.

Other University of Florida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03354364.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing